Supernus Pharmaceuticals recalls

Supernus Pharmaceuticals has 3 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 9 Sep 2026. 2 are still ongoing. 2 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls3since 2016

Last 12 months2reported

Class I00% of total

Ongoing2latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 1Jul 0 1

Severity split

Class I 0 0%Class II 1 33%Class III 2 67%

Why supernus pharmaceuticals is recalled

Potency & Assay3100%

Product types

Seizure Medication3100%

By year

2026267%
2016133%

Ongoing supernus pharmaceuticals recalls

2 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Trokendi XR, (topiramate) extended-release capsules, 50 mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Trokendi XR, topiramate extended-release capsules, 25mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide

All supernus pharmaceuticals recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Trokendi XR, (topiramate) extended-release capsules, 50 mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS III	Trokendi XR, topiramate extended-release capsules, 25mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide
26 Oct 2016Drug	CLASS II	Trokendi XR (topiramate) extended-release capsule, 50mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.